Skip to main content
OpenTrials

Clinical trial condition

Bronchiolitis Obliterans

Explore clinical trials studying Bronchiolitis Obliterans. Study availability and eligibility vary by location and protocol.

520 public trials 84 recruiting studies
Refine in advanced search Browse all conditions

Bronchiolitis Obliterans trial results

Recruiting

Efficacy of an Anti-TSLP Monoclonal Antibody in the Management of Chronic Bronchial Disease Induced by Bronchiolitis Obliterans Syndrome in Allogeneic Hematopoietic Stem Cells Transplantation Recipients

NCT07771855

Conditions
Bronchial Disease, Bronchial Diseases, Bronchiolitis, +11 more
Locations
  • CHU de Besançon Besançon, France
  • Hôpital Haut-Lévêque - CHU Bordeaux Bordeaux, France
  • CHU Caen Normandie Caen, France
  • CHRU de Lille Lille, France
View Trial Details
Recruiting

Axatilimab for Sclerotic Chronic Graft-versus-Host Disease

NCT07011810

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +9 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Recruiting

Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients

NCT06476132

Conditions
Acute Lung Injury, Bronchial Diseases, Bronchiolitis, +8 more
Locations
  • University of California, Los Angeles (Site #: 71123) Los Angeles, California, United States
  • Stanford University (Site #: 71141) Palo Alto, California, United States
  • Johns Hopkins (Site #: 71119) Baltimore, Maryland, United States
  • University of Minnesota (Site 71151) Minneapolis, Minnesota, United States
View Trial Details
Recruiting

A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

NCT06585774

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +9 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • University of Arizona Cancer Center-Out Pt. Tucson, Arizona, United States
  • University of California San Diego Medical Center, Moores Cancer Center La Jolla, California, United States
  • University of Southern California Los Angeles, California, United States
View all 126 locations
View Trial Details
Recruiting

Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy

NCT06660355

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +9 more
Locations
  • Univ of Miami - Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Kansas Cancer Center Kansas City, Kansas, United States
  • University of Virginia Comprehensive Cancer Center Charlottesville, Virginia, United States
View Trial Details
Recruiting

A Long-term Extension Study of PCI-32765 (Ibrutinib)

NCT01804686

Conditions
Blood Protein Disorders, Bronchial Diseases, Bronchiolitis, +43 more
Locations
  • City of Hope Cancer Center Duarte, California, United States
  • University of California San Diego Medical Center La Jolla, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • St. Joseph Hospital Center for Cancer Prevention and Treatment Orange, California, United States
View all 175 locations
View Trial Details

Related conditions